NDC 17088-0114 – Everolimus
Everolimus 5 mg/1 · Tablet, For Suspension
Product NDC17088-0114
Product details
- Brand name
- Everolimus
- Generic name
- Everolimus
- Labeler
- Novartis Pharma Stein AG
- Dosage form
- Tablet, For Suspension
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- August 29, 2012
- Listing expires
- December 31, 2026
Active ingredients
- Everolimus 5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17088-0114-1 | 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0114-1) |
Other Everolimus products
- 60219-2280 Everolimus 3 mg/1 · Tablet, For Suspension · Amneal Pharmaceuticals NY LLC
- 60219-2279 Everolimus 2 mg/1 · Tablet, For Suspension · Amneal Pharmaceuticals NY LLC
- 60219-2281 Everolimus 5 mg/1 · Tablet, For Suspension · Amneal Pharmaceuticals NY LLC
- 70377-091 Everolimus 3 mg/1 · Tablet, For Suspension · Biocon Pharma Inc.
- 70377-090 Everolimus 2 mg/1 · Tablet, For Suspension · Biocon Pharma Inc.
- 70377-092 Everolimus 5 mg/1 · Tablet, For Suspension · Biocon Pharma Inc.
- 51991-991 Everolimus 3 mg/1 · Tablet, For Suspension · Breckenridge Pharmaceutical, Inc.
- 51991-992 Everolimus 5 mg/1 · Tablet, For Suspension · Breckenridge Pharmaceutical, Inc.
- 51991-990 Everolimus 2 mg/1 · Tablet, For Suspension · Breckenridge Pharmaceutical, Inc.
- 17088-0247 Everolimus 2 mg/1 · Tablet, For Suspension · Novartis Pharma Stein AG
- 17088-0107 Everolimus 3 mg/1 · Tablet, For Suspension · Novartis Pharma Stein AG
- 67877-719 Everolimus .5 mg/1 · Tablet · Ascend Laboratories, LLC